long intergenic non-protein coding RNA 2044Genealiases: []
Q-omics provides the consensus-scored LINC02044 profile across patient tissues and cancer cell-line models. LINC02044 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, LINC02044 is differentially expressed in 12, with the highest sampling consensus in KICH. Additionally, LINC02044 RNA expression shows 14,261 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight READ, KICH, and TGCT as cancer lineages where LINC02044 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02044 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02044 survival associations across molecular data types. LINC02044 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02044 RNA expression–survival associations across cancer types. High LINC02044 expression shows unfavorable associations in OV, but favorable associations in READ, CESC, PAAD, ESCA and LGG. The READ Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for LINC02044 RNA expression.
This table summarizes LINC02044 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02044. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02044 shows lower tumor expression in KICH, UCEC, BRCA and KIRP and higher tumor expression in THCA and CHOL. The KICH box plot shows higher LINC02044 RNA expression in normal versus tumor tissue (log2 FC = −0.255, t-test p < 0.001).
This table shows molecular features associated with LINC02044 in patient tissues and cancer cell lines. In patient samples, LINC02044 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
